| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.40B | 66.69B | 65.15B | 64.13B | 62.74B | 55.51B |
| Gross Profit | 9.17B | 9.62B | 9.07B | 8.83B | 8.32B | 7.32B |
| EBITDA | 2.76B | 3.06B | 3.78B | 3.00B | 2.49B | 1.47B |
| Net Income | 1.59B | 2.36B | 2.19B | 1.85B | 1.51B | 1.37B |
Balance Sheet | ||||||
| Total Assets | 72.22B | 77.83B | 73.20B | 79.50B | 69.29B | 60.85B |
| Cash, Cash Equivalents and Short-Term Investments | 6.53B | 8.12B | 7.23B | 9.70B | 8.40B | 7.48B |
| Total Debt | 4.21B | 2.66B | 3.29B | 6.32B | 4.94B | 2.77B |
| Total Liabilities | 42.65B | 44.05B | 43.66B | 50.04B | 42.85B | 35.62B |
| Stockholders Equity | 29.57B | 33.77B | 29.54B | 29.46B | 26.44B | 25.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.69B | 620.00M | 883.00M | -574.00M | 293.00M |
| Operating Cash Flow | 0.00 | 2.05B | 3.29B | 3.43B | 215.00M | 452.00M |
| Investing Cash Flow | 0.00 | 491.00M | -1.84B | -2.31B | -669.00M | 594.00M |
| Financing Cash Flow | 0.00 | -1.50B | -3.91B | 147.00M | 1.34B | -4.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥187.27B | 13.86 | 4.41% | 3.80% | -4.32% | 27.07% | |
70 Outperform | ¥198.09B | 10.74 | ― | 4.09% | -2.00% | 23.48% | |
68 Neutral | ¥23.25B | 10.47 | ― | 3.99% | 2.37% | 7.33% | |
64 Neutral | ¥875.08B | 20.61 | 4.79% | 4.21% | -4.09% | -27.31% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥307.69B | 18.03 | ― | 5.28% | -2.31% | -1.17% | |
56 Neutral | ¥385.81B | 24.59 | -4.00% | 3.71% | -4.00% | ― |